These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 32645141)

  • 1. The Phosphodiesterase-4 Inhibitor Roflumilast, a Potential Treatment for the Comorbidity of Memory Loss and Depression in Alzheimer's Disease: A Preclinical Study in APP/PS1 Transgenic Mice.
    Wang H; Zhang FF; Xu Y; Fu HR; Wang XD; Wang L; Chen W; Xu XY; Gao YF; Zhang JG; Zhang HT
    Int J Neuropsychopharmacol; 2020 Dec; 23(10):700-711. PubMed ID: 32645141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects.
    Feng H; Wang C; He W; Wu X; Li S; Zeng Z; Wei M; He B
    Metab Brain Dis; 2019 Apr; 34(2):583-591. PubMed ID: 30610438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
    Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
    Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and anti-inflammatory effects.
    Guo H; Cheng Y; Wang C; Wu J; Zou Z; Niu B; Yu H; Wang H; Xu J
    Neuropharmacology; 2017 Apr; 116():260-269. PubMed ID: 28065587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roflumilast and tadalafil improve learning and memory deficits in intracerebroventricular Aβ1-42 rat model of Alzheimer's disease through modulations of hippocampal cAMP/cGMP/BDNF signaling pathway.
    Hasan N; Zameer S; Najmi AK; Parvez S; Yar MS; Akhtar M
    Pharmacol Rep; 2021 Oct; 73(5):1287-1302. PubMed ID: 33860460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats.
    Jabaris SG; Sumathy H; Kumar RS; Narayanan S; Thanikachalam S; Babu CS
    Eur J Pharmacol; 2015 Jan; 746():138-47. PubMed ID: 25446433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses.
    Vanmierlo T; Creemers P; Akkerman S; van Duinen M; Sambeth A; De Vry J; Uz T; Blokland A; Prickaerts J
    Behav Brain Res; 2016 Apr; 303():26-33. PubMed ID: 26794595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rolipram Ameliorates Memory Deficits and Depression-Like Behavior in APP/PS1/tau Triple Transgenic Mice: Involvement of Neuroinflammation and Apoptosis via cAMP Signaling.
    Cong YF; Liu FW; Xu L; Song SS; Shen XR; Liu D; Hou XQ; Zhang HT
    Int J Neuropsychopharmacol; 2023 Sep; 26(9):585-598. PubMed ID: 37490542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roflumilast promotes memory recovery and attenuates white matter injury in aged rats subjected to chronic cerebral hypoperfusion.
    Santiago A; Soares LM; Schepers M; Milani H; Vanmierlo T; Prickaerts J; Weffort de Oliveira RM
    Neuropharmacology; 2018 Aug; 138():360-370. PubMed ID: 29933009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer's Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway.
    Hasan N; Zameer S; Najmi AK; Parvez S; Akhtar M
    Neurotox Res; 2022 Apr; 40(2):432-448. PubMed ID: 35192144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute treatment with the PDE4 inhibitor roflumilast improves verbal word memory in healthy old individuals: a double-blind placebo-controlled study.
    Blokland A; Van Duinen MA; Sambeth A; Heckman PRA; Tsai M; Lahu G; Uz T; Prickaerts J
    Neurobiol Aging; 2019 May; 77():37-43. PubMed ID: 30776650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25-35 or Aβ1-40 peptide in rats.
    Cheng YF; Wang C; Lin HB; Li YF; Huang Y; Xu JP; Zhang HT
    Psychopharmacology (Berl); 2010 Oct; 212(2):181-91. PubMed ID: 20640406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-Treatment with the Herbal Medicine SIP3 and Donepezil Improves Memory and Depression in the Mouse Model of Alzheimer's Disease.
    Liu QF; Choi H; Son T; Kim YM; Kanmani S; Chin YW; Kim SN; Kim KK; Kim KW; Koo BS
    Curr Alzheimer Res; 2022; 19(3):246-263. PubMed ID: 35422218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sub-efficacious doses of phosphodiesterase 4 and 5 inhibitors improve memory in a mouse model of Alzheimer's disease.
    Gulisano W; Tropea MR; Arancio O; Palmeri A; Puzzo D
    Neuropharmacology; 2018 Aug; 138():151-159. PubMed ID: 29885420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice.
    Gong Z; Huang J; Xu B; Ou Z; Zhang L; Lin X; Ye X; Kong X; Long D; Sun X; He X; Xu L; Li Q; Xuan A
    J Neuroinflammation; 2019 Mar; 16(1):62. PubMed ID: 30871577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling.
    Li YF; Cheng YF; Huang Y; Conti M; Wilson SP; O'Donnell JM; Zhang HT
    J Neurosci; 2011 Jan; 31(1):172-83. PubMed ID: 21209202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WBQ5187, a Multitarget Directed Agent, Ameliorates Cognitive Impairment in a Transgenic Mouse Model of Alzheimer's Disease and Modulates Cerebral β-Amyloid, Gliosis, cAMP Levels, and Neurodegeneration.
    Wang Z; Cao M; Xiang H; Wang W; Feng X; Yang X
    ACS Chem Neurosci; 2019 Dec; 10(12):4787-4799. PubMed ID: 31697472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Icariin, a phosphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling.
    Jin F; Gong QH; Xu YS; Wang LN; Jin H; Li F; Li LS; Ma YM; Shi JS
    Int J Neuropsychopharmacol; 2014 Jun; 17(6):871-81. PubMed ID: 24513083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GW9508 ameliorates cognitive impairment via the cAMP-CREB and JNK pathways in APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Gong Y; Chen J; Jin Y; Wang C; Zheng M; He L
    Neuropharmacology; 2020 Mar; 164():107899. PubMed ID: 31809762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roflumilast attenuates cognitive deficits in estrogen insufficient rats.
    Goyal A; Garabadu D
    Behav Pharmacol; 2020 Oct; 31(7):671-687. PubMed ID: 32516271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.